Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. PCC Rokita's Revenue for the
three
months ended in Mar. 2026 was zł432 Mil. PCC Rokita's average Accounts Receivable for the
three
months ended in Mar. 2026 was zł219 Mil.
Hence, PCC Rokita's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.97.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
PCC Rokita Receivables Turnover Related Terms
PCC Rokita Receivables Turnover Historical Data
* Premium members only.
The historical data trend for PCC Rokita's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, PCC Rokita's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PCC Rokita Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, PCC Rokita's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where PCC Rokita's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PCC Rokita (WAR:PCR) has a Receivables Turnover of 1.97 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PCC Rokita and its competitors. According to the industry distribution chart, PCC Rokita ranks #474 out of 1577 companies in the Chemicals industry, placing it in the top 30.1%.
Is PCC Rokita's Receivables Turnover too high?
PCC Rokita's current Receivables Turnover is 1.97. The Chemicals industry median Receivables Turnover is 5.60. PCC Rokita's value of 1.97 is 64.8% below this industry median. Based on the distribution chart, PCC Rokita ranks #474 out of 1577 companies in the Chemicals industry, which is above the industry midpoint. Overall, PCC Rokita has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's Receivables Turnover compare to DOW?
According to the Chemicals industry distribution chart, PCC Rokita ranks #474 out of 1577 companies for Receivables Turnover. This puts PCC Rokita in the upper half of its industry. The industry median Receivables Turnover is 5.60. PCC Rokita's value of 1.97 is 64.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.60, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PCC Rokita's current Receivables Turnover of 1.97 is 64.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PCC Rokita and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PCC Rokita's current Receivables Turnover is 1.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (WAR:PCR) is currently considered Fairly Valued. The stock's GF Value™ is zł66.24, compared to a current price of zł69.50 — trading 4.9% above its estimated fair value. The current Receivables Turnover is 1.97 and 64.8% below the Chemicals industry median of 5.60. PCC Rokita's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For PCC Rokita (WAR:PCR), the current Receivables Turnover is 1.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PCC Rokita (WAR:PCR) Overvalued in 2026?
Based on GuruFocus' analysis, PCC Rokita stock appears to be overvalued.
The current stock price of zł69.50 is trading 4.9% above its estimated GF Value™ of zł66.24.
GuruFocus considers PCC Rokita to be Fairly Valued.
Key valuation signals for WAR:PCR:
Receivables Turnover: 1.97
GF Value™: zł66.24 vs. price of zł69.50 (4.9% above fair value)
Industry Position: 64.8% below the Chemicals median (#474 of 1577)
No single metric tells the full story. See the WAR:PCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
82GF Score
Get the complete analysis for WAR:PCR
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PCR has been successfully added to your 
